EA200000860A1 - Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты) - Google Patents

Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)

Info

Publication number
EA200000860A1
EA200000860A1 EA200000860A EA200000860A EA200000860A1 EA 200000860 A1 EA200000860 A1 EA 200000860A1 EA 200000860 A EA200000860 A EA 200000860A EA 200000860 A EA200000860 A EA 200000860A EA 200000860 A1 EA200000860 A1 EA 200000860A1
Authority
EA
Eurasian Patent Office
Prior art keywords
variants
options
bacterial infection
polynucleotides
polypeptide
Prior art date
Application number
EA200000860A
Other languages
English (en)
Inventor
Мартин Бойе
Бернар Р. Бродор
Дени Мартин
Клеман Риу
Хосе Хамель
Изабель Шарльбуа
Original Assignee
Байокем Фармэ Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байокем Фармэ Инк. filed Critical Байокем Фармэ Инк.
Publication of EA200000860A1 publication Critical patent/EA200000860A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Представлены белки Streptococcus группы B (GBS) и кодирующие их полинуклеотиды. Данные белки являются антигенными и вследствие этого используются как вакцинные компоненты для профилактики или терапии стрептококковых инфекций у животных. Кроме того описаны рекомбинантные способы получения белковых антигенов, а также диагностические анализы для детекции стрептококковой бактериальной инфекции.Отчет о международном поиске был опубликован 2000.03.23.
EA200000860A 1998-02-20 1999-02-17 Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты) EA200000860A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7542598P 1998-02-20 1998-02-20
PCT/CA1999/000114 WO1999042588A2 (en) 1998-02-20 1999-02-17 Group b streptococcus antigens

Publications (1)

Publication Number Publication Date
EA200000860A1 true EA200000860A1 (ru) 2001-10-22

Family

ID=22125658

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000860A EA200000860A1 (ru) 1998-02-20 1999-02-17 Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)

Country Status (22)

Country Link
US (4) US20030031682A1 (ru)
EP (3) EP1054971B1 (ru)
JP (2) JP4637350B2 (ru)
KR (1) KR100771148B1 (ru)
CN (2) CN1944652A (ru)
AP (1) AP2000001886A0 (ru)
AT (1) ATE347600T1 (ru)
AU (1) AU2505999A (ru)
CA (1) CA2321106C (ru)
CZ (1) CZ301056B6 (ru)
DE (1) DE69934299T2 (ru)
EA (1) EA200000860A1 (ru)
ES (2) ES2540281T3 (ru)
HU (1) HU228497B1 (ru)
ID (1) ID27482A (ru)
IL (3) IL137921A0 (ru)
NO (2) NO330491B1 (ru)
NZ (1) NZ529854A (ru)
OA (1) OA11686A (ru)
TR (1) TR200002437T2 (ru)
WO (1) WO1999042588A2 (ru)
ZA (1) ZA991325B (ru)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2000001886A0 (en) * 1998-02-20 2000-09-30 Iaf Biochem Int Group B streptococcus antigens.
CA2337102A1 (en) * 1998-07-27 2000-02-10 Richard William Falla Le Page Nucleic acids and proteins from group b streptococcus
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
EP1141308B1 (en) 1998-12-22 2007-02-07 Microscience Limited Group b streptococcus proteins, and their use
GB0105922D0 (en) * 2001-03-09 2001-04-25 Microscience Ltd Genes and proteins, and their use
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
CA2382795A1 (en) * 1999-08-25 2001-03-01 Medimmune, Inc. Homologs of a pneumococcal protein and fragments for vaccines
US6833356B1 (en) 1999-08-25 2004-12-21 Medimmune, Inc. Pneumococcal protein homologs and fragments for vaccines
EP1294771B1 (en) 2000-06-12 2008-10-29 University Of Saskatchewan Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
DK1332155T3 (da) * 2000-06-12 2007-02-26 Univ Saskatchewan Vaccination af malkekvæg med GapC protein mod streptokokinfektion
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
EP1734050A3 (en) * 2000-06-12 2012-12-05 University Of Saskatchewan Immunization of dairy cattle with GapC protein against streptococcus infection
WO2002031156A2 (en) 2000-10-13 2002-04-18 Shire Biochem Inc. Bvh-a2 and bvh-a3 antigens of group b streptococcus
MXPA03003690A (es) 2000-10-27 2004-05-05 Chiron Spa Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
CA2475821C (en) * 2002-02-11 2011-12-13 Shire Biochem Inc. Group b streptococcus antigens
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
EP1648500B1 (en) 2003-07-31 2014-07-09 Novartis Vaccines and Diagnostics, Inc. Immunogenic compositions for streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
EP2612679A1 (en) 2004-07-29 2013-07-10 Novartis Vaccines and Diagnostics, Inc. Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
JP2008544949A (ja) 2004-10-08 2008-12-11 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 化膿性レンサ球菌のための免疫激性組成物および治療用組成物
CA2597170A1 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biological S North America Pharmaceutical compositions
GB0605247D0 (en) * 2006-03-15 2006-04-26 Chiron Srl Compositions and methods for immunisation
KR101621837B1 (ko) 2007-09-12 2016-05-17 노파르티스 아게 Ｇａｓ57 돌연변이 항원 및 ｇａｓ57 항체
CN104292312A (zh) 2007-12-21 2015-01-21 诺华股份有限公司 链球菌溶血素o的突变形式
CN102304185A (zh) * 2011-09-02 2012-01-04 黑龙江八一农垦大学 预防奶牛乳房炎的融合蛋白sip-trap及制备方法和应用
EP2949340A1 (en) * 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5472696A (en) * 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5679768A (en) * 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5225331A (en) * 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
CA2158658A1 (en) 1993-03-19 1994-09-29 Margaretha Stalhammar-Carlemalm Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
US5595740A (en) * 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
EP0754703A4 (en) * 1994-11-01 1999-11-24 Kirin Brewery PEPTIDE SEQUENCE FORMING A MUCIN CHAIN AND TECHNIQUE FOR MODIFYING THE PROTEIN TO BE LINKED TO THE MUCIN CHAIN
EP0941335A2 (en) * 1996-10-31 1999-09-15 Human Genome Sciences Streptococcus pneumoniae polynucleotides and sequences
AP2000001886A0 (en) * 1998-02-20 2000-09-30 Iaf Biochem Int Group B streptococcus antigens.
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
CA2337102A1 (en) 1998-07-27 2000-02-10 Richard William Falla Le Page Nucleic acids and proteins from group b streptococcus
JP4689044B2 (ja) 1998-12-21 2011-05-25 メディミューン，インコーポレーテッド ワクチン用の肺炎連鎖球菌タンパク質と免疫原断片
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
KR100802198B1 (ko) 1998-12-23 2008-02-11 샤이어 바이오켐 인코포레이티드 신규한 스트렙토코커스 항원
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
CA2475821C (en) 2002-02-11 2011-12-13 Shire Biochem Inc. Group b streptococcus antigens

Also Published As

Publication number Publication date
US20030228323A1 (en) 2003-12-11
DE69934299D1 (de) 2007-01-18
ATE347600T1 (de) 2006-12-15
CZ20003054A3 (cs) 2001-03-14
US20030031682A1 (en) 2003-02-13
IL190018A0 (en) 2008-08-07
EP1757697A2 (en) 2007-02-28
CA2321106C (en) 2013-07-23
NO20004161L (no) 2000-10-19
ES2540281T3 (es) 2015-07-09
HU228497B1 (en) 2013-03-28
IL137921A (en) 2008-06-05
KR20010034518A (ko) 2001-04-25
NO20004161D0 (no) 2000-08-18
US20110182923A1 (en) 2011-07-28
EP1054971A2 (en) 2000-11-29
US7914794B2 (en) 2011-03-29
EP1054971B1 (en) 2006-12-06
IL190018A (en) 2011-07-31
AU2505999A (en) 1999-09-06
NO330491B1 (no) 2011-05-02
JP2009242403A (ja) 2009-10-22
DE69934299T2 (de) 2007-07-05
US20130095498A1 (en) 2013-04-18
ES2278436T3 (es) 2007-08-01
CN1268745C (zh) 2006-08-09
JP2002507396A (ja) 2002-03-12
IL137921A0 (en) 2001-10-31
WO1999042588A3 (en) 2000-03-23
EP2280072B1 (en) 2015-03-25
US8580262B2 (en) 2013-11-12
HUP0102304A3 (en) 2008-03-28
ZA991325B (en) 1999-08-20
CZ301056B6 (cs) 2009-10-29
NO20101682L (no) 2000-10-19
EP2280072A3 (en) 2012-06-06
AP2000001886A0 (en) 2000-09-30
TR200002437T2 (tr) 2000-11-21
KR100771148B1 (ko) 2007-10-29
OA11686A (en) 2005-01-12
EP2280072A2 (en) 2011-02-02
JP4637350B2 (ja) 2011-02-23
CN1944652A (zh) 2007-04-11
NZ529854A (en) 2005-08-26
US8226953B2 (en) 2012-07-24
ID27482A (id) 2001-04-12
CN1297482A (zh) 2001-05-30
EP1757697A3 (en) 2007-05-30
HUP0102304A1 (hu) 2001-10-28
CA2321106A1 (en) 1999-08-26
WO1999042588A2 (en) 1999-08-26

Similar Documents

Publication Publication Date Title
EA200000860A1 (ru) Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)
EA200201280A1 (ru) Стрептококковые антигены
EA200100565A1 (ru) Новые стрептококковые антигены
EE200200709A (et) Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
DK0950068T3 (da) Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse
ATE430200T1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
ZA965482B (en) Novel antigen.
NO329875B1 (no) Isolert DNA-sekvens som koder for svinereproduktive- og respiratoriske syndromvirus (PRRSV), en sammensetning omfattende polypeptidene kodet av denne, en sammensetning for indusering av antistoffer mot PRRSV, anvendelse av sammensetning for fremstilling av vaksine og fremgangsmate for a skille PRRSV-stamme ISU-55 fra andre PRRSV-stammer.
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
ATE109512T1 (de) Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
CN1195993A (zh) 抗胃肠疾病的鼻内接种
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
ATE124420T1 (de) Impfstoffe und testsätze für haemophilus influenzae.
HUP0100130A2 (hu) Rekombináns Mycoplasma hyopneumoniae vakcina
GB9401689D0 (en) Diagnosis and treatment of endocarditis
CA2284110A1 (en) An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
RU2000131225A (ru) Белки moraxella catarrhalis
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
NO923828L (no) Polypeptider, nyttige til diagnose av og behandling mot mycoplasma-infeksjoner hos dyr
EP1950302A3 (en) Streptococcus antigens
HUP9900766A2 (hu) Helicobacter pylorival kapcsolatos nukleinsav- és aminosavszekvenciák diagnosztikumokhoz és gyógyszerekhez
RU97115365A (ru) Антиген helicobacter pylori
RU92004487A (ru) Днк, полипептид, вакцина, вектор, микроорганизм, клетка насекомого, реагент, способы лечения и профилактики, способ обнаружения антигенов